< Back to latest news & events

Event

HGF are Platinum Sponsors of the Dublin IP and R&D Summit

August 2024

HGF is proud to be Platinum sponsors of the IP and R&D Summit, taking place on the 4th and 5th of September 2024. This two day event will be held at the following venues:

Day 1Enterprise Ireland Offices, Ireland 

Day 2The Convention Centre Dublin, Ireland

On day 1, Craig Thomson will be moderating a panel session on: IP Strategy for SMEs and Innovators. This panel will discuss IP strategies for start-ups, focusing on safeguarding ideas and navigating legal complexities.

Panelists:

  • Craig Thomson, Partner & Patent Attorney, HGF
  • Eoin McManus, General Counsel, Klas
  • Pat Fitzgerald, CEO, Beotanics Ltd.
  • Michelle Tierney, Co-Founder & CSO, Mbryonics Ltd.
  • Donal O’Sullivan, CEO, Nutribio

Sean McDonagh will deliver a fireside chat on: Building a Brand Identity for Your Business, alongside Joe Doyle. They will explore how businesses can create and protect strong brand identities.

Sean will also be moderating a panel session on Day 2 of the event, on: Trade Mark Trends – Combating Counterfeiting and Navigating Dispute Resolution. This panel will cover strategies for trade mark protection, dispute resolution, and tackling AI-driven counterfeiting.

Panelists:

  • Sean McDonagh, Trade Mark Director, HGF
  • Ralf Duckeck, VP Intellectual Property, ebm-papst Group
  • Nancy Rowe, Global Head of Trade Marks, Bausch + Lomb
  • Pascal van Troost, Global Intellectual Property Director, Gates
  • Inge Buffollo, Director Business Development, EUIPO

HGF Partners Marie Walsh , Jason Lessard and Andrew McGettrick will also be attending and are looking forward to connecting with industry leaders at the event.

For more details, click the button below.

 

Latest updates

The concept of ‘overall impression’ in UK and EU Registered Design Law

 

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 7th January 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article